Analysis of the single‐cell dataset of osimertinib‐treated lung cancer patients also indicated higher expression of DPP4 in the residual cancer cells (Figure 1H–I; Figure S4G–L, Supporting Information). Here, DPP4 is linked to lung carcinoma.